LAUSR

Obesity, Senescence, and Senolytics.

Sign Up to like & get
recommendations!
0 Published in 2021 at "Handbook of experimental pharmacology"

DOI: 10.1007/164_2021_555

Abstract: Obesity is a major risk factor for the development of comorbidities such as type 2 diabetes, neurodegenerative disorders, osteoarthritis, cancer, cardiovascular and renal diseases. The onset of obesity is linked to an increase of senescent… read more here.

Keywords: senescent cells; obesity senescence; senescence; senescence senolytics ... See more keywords